The upcoming report from CareDx (CDNA) is expected to reveal quarterly loss of $0.19 per share, indicating a decline of 72.7% compared to the year-ago period. Analysts forecast revenues of $63.63 ...
Key Insights Using the 2 Stage Free Cash Flow to Equity, CareDx fair value estimate is US$10.63 CareDx is estimated ...
CareDx (CDNA) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #1 (Strong Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates -- ...
Zacks Investment Research on MSN
CareDx (CDNA) Surges 7.0%: Is This an Indication of Further Gains?
CareDx CDNA shares soared 7% in the last trading session to close at $12.75. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the ...
Craig-Hallum analyst Alexander Nowak maintained a Hold rating on CareDx (CDNA – Research Report) today. The company’s shares closed yesterday at $9.64. Nowak covers the Healthcare sector, focusing on ...
AZoLifeSciences on MSN
What are Hidden RNAs and How Can You Identify Them in RNA-Seq Data?
Discover the biological significance of hidden RNAs and learn how to detect them in RNA-Seq data using advanced techniques.
CareDx, Inc. (NASDAQ:CDNA) faces fresh uncertainty as proposed reimbursement changes threaten its core testing business, clouding near-term growth even as the company’s expanding transplant solutions ...
H.C. Wainwright analyst Yi Chen reiterated a Hold rating on CareDx (CDNA – Research Report) today. The company’s shares closed yesterday at $22.93. Chen covers the Healthcare sector, focusing on ...
AMD's new Instinct MI325X AI accelerator will use the same CDNA 3 architecture as the just-launched Instinct MI300 series AI accelerators, with a monster 288GB of HBM3E memory with up to 6TB/sec of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback